Introduction:Basic information about CAS 12001-79-5|Vitamin K, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Vitamin K |
|---|
| CAS Number | 12001-79-5 | Molecular Weight | 450.69600 |
|---|
| Density | 0.963g/cm3 | Boiling Point | 546.4ºC at 760mmHg |
|---|
| Molecular Formula | C31H46O2 | Melting Point | 112-114ºC |
|---|
| MSDS | / | Flash Point | 200.4ºC |
|---|
Names
| Name | vitamin k1 |
|---|
| Synonym | More Synonyms |
|---|
Vitamin K BiologicalActivity
| Description | Vitamin K is a group of fat soluble vitamins, important for the function of numerous proteins within the body, such as the coagulation factors, osteocalcin and matrix-Gla protein. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Cardiovascular Disease |
|---|
| In Vitro | Phylloquinone (vitamin K1) and Menaquinones (vitamin K2) are the two naturally occurring forms of vitamin K. Phylloquionone is the major dietary source of vitamin K and is found at highest concentrations in green leafy vegetables[1]. Vitamin K2 (menaquinone) is found in small amounts in chicken, butter, egg yolks, cheese and fermented soyabeans. Vitamin K1 and vitamin K2 are required for the γ-glutamyl carboxylation of all vitamin K-dependent proteins[2]. Vitamin K has important actions in the nervous system. Vitamin K contributes to the biological activation of proteins Gas6 and protein S, ligands for the receptor tyrosine kinases of the TAM family (Tyro3, Axl, and Mer). In brain, vitamin K also participates in the synthesis of sphingolipids, an important class of lipids present in high concentrations in brain cell membranes[3]. |
|---|
| In Vivo | Vitamin K is well-known for its function in blood coagulation. Several human studies report the beneficial role of vitamin K supplementation in improving insulin sensitivity and glucose tolerance, preventing insulin resistance, and reducing the risk of type 2 diabetes[1]. The adequate intake for vitamin K has been proposed to be 90 µg/day for women and 120 µg/day for men[2]. Vitamin K deficiency results in an increase in undercarboxylated osteocalcin, a protein with low biological activity. Several studies have demonstrated that low dietary vitamin K intake is associated with low bone mineral density or increased fractures. Additionally, vitamin K supplementation has been shown to reduce undercarboxylated osteocalcin and improve the bone turnover profile[4]. |
|---|
| References | [1]. Manna P, et al. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review. Nutrition. 2016 Jul-Aug;32(7-8):732-9. [2]. DiNicolantonio JJ, et al. The health benefits of vitamin K. Open Heart. 2015 Oct 6;2(1):e000300. [3]. Ferland G, et al. Vitamin K, an emerging nutrient in brain function. Biofactors. 2012 Mar-Apr;38(2):151-7. [4]. Bügel S, et al. Vitamin K and bone health. Proc Nutr Soc. 2003 Nov;62(4):839-43. |
|---|
Chemical & Physical Properties
| Density | 0.963g/cm3 |
|---|
| Boiling Point | 546.4ºC at 760mmHg |
|---|
| Melting Point | 112-114ºC |
|---|
| Molecular Formula | C31H46O2 |
|---|
| Molecular Weight | 450.69600 |
|---|
| Flash Point | 200.4ºC |
|---|
| Exact Mass | 450.35000 |
|---|
| PSA | 34.14000 |
|---|
| LogP | 9.15760 |
|---|
| Appearance of Characters | viscous liquid |
|---|
| Vapour Pressure | 5.37E-12mmHg at 25°C |
|---|
| Index of Refraction | n20/D 1.527(lit.) |
|---|
| InChIKey | MBWXNTAXLNYFJB-LKUDQCMESA-N |
|---|
| SMILES | CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C |
|---|
| Storage condition | 2-8°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- ZA9040000
- CHEMICAL NAME :
- Vitamin K
- CAS REGISTRY NUMBER :
- 12001-79-5
- LAST UPDATED :
- 199701
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 700 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 8,25,1958 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- DOSE :
- 13500 ug/kg
- SEX/DURATION :
- female 6-11 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- REFERENCE :
- CAJPBD Proceedings of the Congenital Anomalies Research Association of Japan. (Kyoto, Japan) No.1- 1961- Volume(issue)/page/year: 8,46,1968 *** REVIEWS *** TOXICOLOGY REVIEW NYSJAM New York State Journal of Medicine. (Medical Soc. of the State of New York, POB 5405, Lake Success, NY 11042) V.1- 1901- Volume(issue)/page/year: 64,493,1964 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80150 No. of Facilities: 168 (estimated) No. of Industries: 2 No. of Occupations: 12 No. of Employees: 2650 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80150 No. of Facilities: 488 (estimated) No. of Industries: 3 No. of Occupations: 14 No. of Employees: 5168 (estimated) No. of Female Employees: 1116 (estimated)
|
Safety Information
| WGK Germany | 2 |
|---|
| RTECS | QJ5800000 |
|---|
Synonyms